Moneycontrol PRO
you are here: HomeNewsOpinion

India data stoke sales optimism for pharma companies

Growth in Indian drug market rebounded in November while flu season is aiding sales in the US

December 15, 2022 / 11:23 AM IST
India data stoke sales optimism for pharma companies

New products and a strong influenza (flu) season are driving sales of pharma companies in the US

Highlights Indian pharma market grew 14.5 percent in November Volumes in Indian market increased after two consecutive months of declines Strong flu season is also driving prescription drug sales in the US Price hikes and new products to drive growth of Indian market in FY23 Latest data indicate encouraging sales in key markets of the Indian pharmaceutical companies. As per IQVIA, the Indian pharmaceutical market expanded 14.5 percent in November. Another data services provider AIOCD AWACS pegs domestic market growth at 17.3 percent. Coincidentally, data from the...

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers